Company News » Juno Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire - January 8, 2015, 13:06 GMT
Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced that it will webcast its presentation at the 33rd Annual J.P. Morgan Healthcare Conference at 8:30 a.m. PST, Wednesday, Jan. 14, 2015. The presentation will feature a business overview and update by Hans Bishop, president and chief executive officer of Juno. The webcast will be accessible on the Investors
Company News » Juno Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesBusiness Wire - December 23, 2014, 21:03 GMT
Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced the closing of its initial public offering of 12.7 million shares of common stock at a price to the public of $24.00 per share, which includes the exercise in full by the underwriters of the offering of their option to purchase 1.7 million shares. Morgan Stanley & Co. LLC,
Company News » Juno Therapeutics Announces Pricing of Initial Public OfferingBusiness Wire - December 18, 2014, 23:15 GMT
Juno Therapeutics, Inc. today announced the pricing of its initial public offering of 11,022,917 shares of common stock at a price to the public of $24.00 per share. In addition, Juno Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,653,437 shares of common stock to cover over-allotments, if any.